Skip to content
value.today

TrialScope, Inc.

🇺🇸 Jersey City, New Jersey, USAPharmaceuticalsFounded 2012
Total raised
$18 M
3 rounds on record
Latest round
$4 M
Sep 2018
First round on record
May 2014
Today
Private
No later event on record

Funding rounds

3 counted as startup funding. Open the number of investors for the round's details.

Funding rounds of TrialScope, Inc.
MonthRaisedRaiseSizeInvestorsSoldFiling
Sep 2018$4 MNo. 3$2 to $10 million

TrialScope, Inc.: Raise no. 3, Sep 2018

Investors in this round

5 investors had bought by the notice of Sep 17, 2018: 5 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $5 M offered; $1 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Jeffrey Kozloff · Executive Officer, Director
  • Matthew C. Patras · Executive Officer
  • James C. Walker · Director
  • Larry C. Berran · Director
  • Marc Lederman · Director
  • Michael Kopelman · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Jeffrey Kozloff, Chief Executive Officer. Source: SEC Form D, newest notice filed Sep 17, 2018. Read the notice at the SEC.

equitySEC
Apr 2017$4 MNo. 2$2 to $10 million

TrialScope, Inc.: Raise no. 2, Apr 2017

Investors in this round

6 investors had bought by the notice of Apr 25, 2017: 6 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$4 M of $4 M offered; $0 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Corporation, incorporated in Delaware

People named in the notice

  • Mark Heinold · Executive Officer, Director
  • Richard C Aguinaldo · Executive Officer
  • Charles C Saldarini · Director
  • Christopher C Noe · Director
  • James A Hill · Director
  • James C Walker · Director
  • Jeffrey C Kozloff · Director
  • Michael A DiPiano · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by Mark Heinold, Chief Executive Officer. Source: SEC Form D, newest notice filed Apr 25, 2017. Read the notice at the SEC.

equitySEC
May 2014$10 MNo. 1$10 to $50 million

TrialScope, Inc.: Raise no. 1, May 2014

Investors in this round

4 investors had bought by the notice of Jun 10, 2014: 4 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$10 M of $10 M offered
Smallest investment taken
no minimum stated
What was sold
equity
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Corporation, incorporated in Delaware

People named in the notice

  • E. Michael Forgash · Executive Officer, Director
  • Chris Michael Noe · Director
  • Eric Michael Jensen · Director
  • Jim Michael Walker · Director
  • Joe Michael Stauffer · Director
  • Michael Michael Balmuth · Director

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Signed by E. Michael Forgash, Chief Executive Officer. Source: SEC Form D, newest notice filed Jun 10, 2014. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • TrialScope, Inc. chose not to state its revenue in its newest notice of a funding round (Sep 2018).

    SEC Form D · Sep 2018

  • The industry group it chose in its notices: Pharmaceuticals.

    SEC Form D · Sep 2018

That is all the official record says: TrialScope, Inc. has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of TrialScope, Inc. is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 3 rounds above had up to 6 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by TrialScope, Inc.
NameRoleNamed in
Jeffrey KozloffExecutive officerSep 2018
Matthew C. PatrasExecutive officerSep 2018
Mark HeinoldExecutive officerApr 2017
Richard C AguinaldoExecutive officerApr 2017
E. Michael ForgashExecutive officerJun 2014
James C. WalkerDirectorSep 2018
Jeffrey KozloffDirectorSep 2018
Larry C. BerranDirectorSep 2018
Marc LedermanDirectorSep 2018
Michael KopelmanDirectorSep 2018
Charles C SaldariniDirectorApr 2017
Christopher C NoeDirectorApr 2017
James A HillDirectorApr 2017
James C WalkerDirectorApr 2017
Jeffrey C KozloffDirectorApr 2017
Mark HeinoldDirectorApr 2017
Michael A DiPianoDirectorApr 2017
Chris Michael NoeDirectorJun 2014
E. Michael ForgashDirectorJun 2014
Eric Michael JensenDirectorJun 2014
Jim Michael WalkerDirectorJun 2014
Joe Michael StaufferDirectorJun 2014
Michael Michael BalmuthDirectorJun 2014